ROCKVILLE, Md., April 27 /PRNewswire-FirstCall/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical
company focused on the development and commercialization of
clinical-stage products for central nervous system disorders, today
announced it will release results for the first quarter of 2010, on
Tuesday, May 4, 2010, before the
market opens. A full text copy of the release will be disseminated
at that time.
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer, will host a conference call
to discuss the results at 9:30 AM ET
on Tuesday, May 4, 2010. Also
participating on the call will be Stephanie
R. Irish, Acting CFO. To participate in the conference call,
dial the appropriate number below shortly before the 9:30 AM start time and ask for the Vanda
Pharmaceuticals conference call hosted by Dr. Polymeropoulos.
The teleconference dial-in numbers are as follows:
Domestic callers 1-866-700-7173
International callers 1-617-213-8838
Participant Passcode 17942676
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com. Investors
should go to the website at least 15 minutes early to register,
download, and install any necessary audio software or company
presentations.
A replay of the call will be available on Tuesday, May 4, 2010, beginning at 12:30 PM ET and will be accessible until
Tuesday, May 11, 2010, at
5:00 PM ET. The replay call-in number
is 1-888-286-8010 for domestic callers and 1-617-801-6888 for
international callers. The access number is 39291542.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of clinical-stage
products for central nervous system disorders. For more on
Vanda Pharmaceuticals Inc., please visit
http://www.vandapharma.com.
Company
Contact:
|
|
|
|
|
|
|
|
Stephanie R.
Irish
|
|
|
|
|
|
|
|
Acting Chief
Financial Officer
|
|
|
|
|
|
|
|
Vanda Pharmaceuticals
Inc.
|
|
|
|
|
|
|
|
(240)
599-4500
|
|
|
|
|
|
|
|
stephanie.irish@vandapharma.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SOURCE Vanda Pharmaceuticals Inc.